GCM
XBI icon

Greenland Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Greenland Capital Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,365
Closed -$590K – 451
2024
Q2 		$590K Buy
6,365
+3,391
+114% +$304K 0.09% 177
2024
Q1 		$282K Buy
+2,974
New +$276K 0.03% 298
2023
Q2 		– Sell
-3,351
Closed -$255K – 400
2023
Q1 		$255K Buy
+3,351
New +$278K 0.03% 280

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Greenland Capital Management's XBI Position: Q3 2024 in Review

Greenland Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 6,365 shares — an estimated $590K sold.

Greenland Capital Management first reported a position in XBI in Q1 2023 and held it in 3 quarters. The position peaked at $590K in Q2 2024. 770 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

  • Greenland Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
  • Greenland Capital Management sold 6,365 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $590K.
  • Greenland Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and held it in 3 quarters.
  • Greenland Capital Management's State Street SPDR S&P Biotech ETF position peaked at $590K in Q2 2024.
  • 770 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Greenland Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.